Notable Labs Inc. (NTBL) Stock
NTBL is no longer traded. Notable Labs was delisted from the Nasdaq in December 2024.
Prices on this page are historical; the last trade was December 23, 2024 at $0.03.
Notable Labs stock price history
NTBL final trading statistics
- Final close
- $0.03
- Final trading day
- Dec 23, 2024
- Market cap at delisting
- $2.39M
- Shares outstanding
- 9.66M
- Final 52-week range
- $0.01 – $2.30
- Avg. volume (final 3 mo.)
- 2,592,782
- All-time high (split-adj.)
- $568.05 · Jan 2015
- All-time low (split-adj.)
- $0.01 · Dec 2024
- Return since IPO
- -100.0%
- Beta
- —
- Book value / share
- $0.74
- Price / book
- 0.03
Notable Labs annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $310.0K | -$11.3M | -$6.37 |
| FY2022 | $8.0K | -$14.4M | -$12.99 |
| FY2021 | $285.0K | -$16.1M | -$15.75 |
| FY2020 | $922.0K | -$24.2M | -$19.60 |
| FY2019 | $562.0K | -$19.4M | -$18.90 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Notable Labs Inc.
Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and enables fast-track therapeutic development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor to induce cell cycle arrest and apoptosis in various cancer cells; and Fosciclopirox, a pro-drug of ciclopirox for acute myeloid leukemia. Notable Labs, Ltd. was incorporated in 2014 and is headquartered in Foster City, California. On October 13, 2024, Notable Labs, Ltd. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Notable Labs stock FAQ
What happened to Notable Labs stock?
Notable Labs stock was delisted from the Nasdaq. Its final close was $0.03 on December 23, 2024.
Is NTBL stock still trading?
No. NTBL was delisted from the Nasdaq in December 2024 and no longer trades on a U.S. exchange.
What was the last price of NTBL stock?
NTBL closed at $0.03 on its final trading day, December 23, 2024, for a market value of about $2.39M.
What were Notable Labs's revenue and earnings in its last full fiscal year?
Notable Labs reported revenue of $310.0K and net income of -$11.3M in fiscal 2023, its last full year as a public company.
When did Notable Labs go public?
Notable Labs Inc. stock began trading on October 17, 2023.